The Global Health Body Issues Alert Over Acute Scarcity of Weight-Loss Injections
Fewer than one in 10 patients who could benefit from obesity jabs such as Wegovy can access them, caution the global health agency as it issues its initial recommendations on the medications.
Considering over a billion individuals worldwide currently classified as obese, it is advocating for increased and just availability to these injectable treatments.
According to projections, more than two billion could be living with obesity by 2030 without intervention.
"The latest guidelines acknowledges that excess weight is a lifelong illness that can be treated with holistic and ongoing support," stated WHO director-general Tedros Adhanom Ghebreyesus.
Substantial prices, insufficient output, and distribution challenges are key hurdles to widespread availability to the jabs that can assist patients in reducing considerable weight, says the agency.
GLP-1 Therapy Supply Crisis
Even under the current best projected case, the production of such drugs could only cover approximately 100 million people – under 10% of those who need them, according to the health organization.
The recommendation urges nations and manufacturers to widen access, through measures such as voluntary licensing.
Exclusive production rights on a key compound – the primary ingredient of a leading brand – is due to expire in several nations in 2026.
The Way Obesity Injections Operate
These medications imitate a biological compound to delay gastric emptying, suppress the appetite and enhance the sense of being full so individuals reduce food intake.
Patients commonly begin shedding pounds within a few weeks of beginning the once-weekly jabs.
Studies suggests people may regain a significant portion after a year of stopping the medication, when their typical hunger come back.
To be above a healthy weight raises your risk for experiencing health problems, like type 2 diabetes, cardiovascular issues, stroke, and certain malignancies.
Excess weight concerns people in every country and was linked to millions of deaths worldwide in 2024, according to the health agency.
